Perspective Therapeutics Inc [AMEX: CATX] traded at a high on Tuesday, posting a 29.29 gain after which it closed the day’ session at $3.09.
The results of the trading session contributed to over 8707481 shares changing hands. Over the past one week, the price volatility of Perspective Therapeutics Inc stands at 15.01% while the volatility over the past one month is 9.34%.
The market cap for CATX stock reached $229.37 million, with 74.05 million shares outstanding and 54.06 million shares in the current float. Compared to the average trading volume of 759.73K shares, CATX reached a trading volume of 8707481 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Perspective Therapeutics Inc [CATX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CATX shares is $13.89 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CATX stock is a recommendation set at 1.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Perspective Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 13, 2025. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Outperform. The new note on the price target was released on March 07, 2025, representing the official price target for Perspective Therapeutics Inc stock. Previously, the target price had yet another drop from $24 to $5, while BofA Securities kept a Neutral rating on CATX stock.
The Average True Range (ATR) for Perspective Therapeutics Inc is set at 0.32, with the Price to Sales ratio for CATX stock in the period of the last 12 months amounting to 156.03. The Price to Book ratio for the last quarter was 0.80, with the Price to Cash per share for the same quarter was set at 2.85.
How has CATX stock performed recently?
Perspective Therapeutics Inc [CATX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.75. With this latest performance, CATX shares gained by 20.70% in over the last four-week period, additionally sinking by -25.00% over the last 6 months – not to mention a drop of -76.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CATX stock in for the last two-week period is set at 63.01, with the RSI for the last a single of trading hit 66.45, and the three-weeks RSI is set at 60.14 for Perspective Therapeutics Inc [CATX]. The present Moving Average for the last 50 days of trading for this stock 2.30, while it was recorded at 2.67 for the last single week of trading, and 6.32 for the last 200 days.
Perspective Therapeutics Inc [CATX]: Deeper insight into the fundamentals
Perspective Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 17.02 and a Current Ratio set at 17.02.
Earnings analysis for Perspective Therapeutics Inc [CATX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CATX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Perspective Therapeutics Inc go to -1.94%.
